• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Devices@FDA

  • Print
  • Share
  • E-mail
-
 
Help | Download Files | More about PMA

New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceSYNVISC, SYNVISC-ONE
Generic Nameacid, hyaluronic, intraarticular
Applicant
Sanofi GENZYME CORP.
50 binney street
cambridge, MA 02142
PMA NumberP940015
Supplement NumberS034
Date Received04/24/2015
Decision Date07/24/2015
Product Code MOZ 
Advisory Committee Orthopedic
Supplement Typereal-time process
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
APPROVAL FOR THE FOLLOWING CHANGES FOR THE DELIVERY SYRINGES FOR SYNVISC® AND SYNVISC-ONE®:1) CHANGE OF THE CLEAR PLASTIC RIGID TIP CAP (PRTC) TO A BLUE PRTC;2) CHANGE OF THE CLEAR POLYSTYRENE PLUNGER ROD, WITH DIAMETERS OF 8.0 MM AND 13.4 MM RESPECTIVELY FOR THE SYNVISC® AND SYNVISC-ONE® SYRINGES, TO A BLUE POLYPROPYLENE PLUNGER ROD WITH DIAMETERS OF 8.2 MM AND 13.7 MM RESPECTIVELY FOR THE SYNVISC® AND SYNVISC-ONE® SYRINGES; 3) CHANGE OF THE THUMB PRESS ON THE PLUNGER ROD FROM A FLAT, SMOOTH SURFACE WITH DIAMETERS OF 12.7 MM AND 18.6 MM RESPECTIVELY FOR THE SYNVISC® AND SYNVISC-ONE® SYRINGES, TO A FLAT, TEXTURED SURFACE WITH DIAMETERS OF 19 MM AND 26.7 MM RESPECTIVELY FOR THE SYNVISC® AND SYNVISC-ONE® SYRINGES; 4) CHANGE OF THE GREY PROPYLENE OVAL-SHAPED FINGER FLANGE, WITH OVERALL WIDTHS OF 28.4 MM AND 43.8 MM RESPECTIVELY FOR THE SYNVISC® AND SYNVISC-ONE® SYRINGES, TO A BLUE PROPYLENE WING-SHAPED FINGER FLANGE, WITH OVERALL WIDTHS OF 35.6 MM AND 43.9 MM RESPECTIVELY FOR THE SYNVISC® AND SYNVISC-ONE® SYRINGES; 5) CHANGE OF THE TRANSPARENT SYRINGE LABEL TO A TRANSLUCENT SYRINGE LABEL WITH GRADED BLUE COLOR; AND6) CHANGE OF THE SYNVISC-ONE® BLISTER TRAY TO INCORPORATE A FINGER FLANGE CAVITY MODIFIED TO ACCOMMODATE THE NEW FLANGE DESIGN.THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME SYNVISC® AND SYNVISC-ONE® AND IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGIC THERAPY AND SIMPLE ANALGESICS, E.G. ACETAMINOPHEN.
  We welcome your comments and feedback about Devices@FDA.
-
-